Pipamperone
Pipamperone is a small molecule pharmaceutical. It is currently being investigated in clinical studies. It is known to target histamine H1 receptor, 5-hydroxytryptamine receptor 1D, 5-hydroxytryptamine receptor 1A, 5-hydroxytryptamine receptor 2A, and 5-hydroxytryptamine receptor 1B.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area | MeSH |
---|---|
mental disorders | D001523 |
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
No data
Indications
FDA
EMA
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
schizophrenia | EFO_0000692 | D012559 | F20 |
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
HCPCS
No data
Clinical
Clinical Trials
4 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Depression | D003863 | F33.9 | — | 1 | 1 | — | — | 2 | |
Dementia | D003704 | F03 | — | — | 1 | — | — | 1 | |
Psychophysiologic disorders | D011602 | F45.9 | — | — | 1 | — | — | 1 | |
Schizophrenia | D012559 | EFO_0000692 | F20 | — | — | 1 | — | — | 1 |
Anxiety disorders | D001008 | EFO_0006788 | F41.1 | — | — | 1 | — | — | 1 |
Major depressive disorder | D003865 | EFO_0003761 | F22 | — | — | 1 | — | — | 1 |
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name | PIPAMPERONE |
INN | pipamperone |
Description | Pipamperone is a member of the class of bipiperidines that is 1,4'-bipiperidine which is substituted at the 1' and 4' positions by 4-(p-fluorophenyl)-4-oxobutyl and carboxamide groups, respectively. A first generation antipsychotic, its properties are generally similar to those of haloperidol. It has a role as a first generation antipsychotic, a serotonergic antagonist and a dopaminergic antagonist. It is a monocarboxylic acid amide, an aromatic ketone, an organofluorine compound, a member of bipiperidines and a tertiary amino compound. It is a conjugate base of a pipamperone(2+). |
Classification | Small molecule |
Drug class | antianxiety agents/neuroleptics (4'-fluoro-4-piperidinobutyrophenone derivatives) |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | NC(=O)C1(N2CCCCC2)CCN(CCCC(=O)c2ccc(F)cc2)CC1 |
Identifiers
PDB | — |
CAS-ID | 1893-33-0 |
RxCUI | 33739 |
ChEMBL ID | CHEMBL440294 |
ChEBI ID | 78549 |
PubChem CID | 4830 |
DrugBank | DB09286 |
UNII ID | 5402501F0W (ChemIDplus, GSRS) |
Target
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 267 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
1,279 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more